These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9716226)

  • 21. Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features.
    Rostaing L; Izopet J; Cisterne JM; Arnaud C; Duffaut M; Rumeau JL; Puel J; Durand D
    Transplantation; 1998 Apr; 65(7):930-6. PubMed ID: 9565097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GB virus C (GBV-C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: effect of interferon alfa therapy.
    Pawlotsky JM; Roudot-Thoraval F; Muerhoff AS; Pellerin M; Germanidis G; Desai SM; Bastie A; Darthuy F; Rémiré J; Zafrani ES; Soussy CJ; Mushahwar IK; Dhumeaux D
    J Med Virol; 1998 Jan; 54(1):26-37. PubMed ID: 9443106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus RNA in patients with anti-HCV on hemodialysis. Relationship to transaminase levels.
    Garcia-Valdecasas J; Bernal C; Cerezo S; Garcia F; Montiel N; Leyva A; Umana WO; Bosch JP
    ASAIO J; 1994; 40(3):M450-3. PubMed ID: 8555556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum hepatitis C virus (HCV) RNA: a reliable tool for evaluating HCV-related liver disease in anti-HCV-positive blood donors with persistently normal alanine aminotransferase values.
    Nalpas B; Romeo R; Pol S; Thiers V; Carnot F; Berthelot P; Brechot C
    Transfusion; 1995 Sep; 35(9):750-3. PubMed ID: 7570935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum HCV RNA titer does not predict the severity of liver damage in HCV carriers with normal aminotransferase levels.
    Puoti C; Stati T; Magrini A
    Liver; 1999 Apr; 19(2):104-9. PubMed ID: 10220739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of hepatitis C virus (HCV)-RNA and--antibody as markers of infection and predictors of infectivity.
    Beardsley AM; LaBrooy JT; Rozen L; Gowans EJ
    Aust N Z J Med; 1994 Apr; 24(2):182-7. PubMed ID: 8042947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
    Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR
    J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon alpha therapy in patients with chronic type C hepatitis: changes of serum ALT, anti-HCV & HCV-RNA.
    Cho HJ; Dong SH; Lee MS; Kim HY; Park CK; Yoo JY; Polito A; Quan S; Han JH
    Korean J Intern Med; 1992 Jan; 7(1):13-7. PubMed ID: 1282364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study.
    Bellentani S; Pozzato G; Saccoccio G; Crovatto M; Crocè LS; Mazzoran L; Masutti F; Cristianini G; Tiribelli C
    Gut; 1999 Jun; 44(6):874-80. PubMed ID: 10323892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up of and infectivity in blood donors with hepatitis C antibodies and persistently normal alanine aminotransferase levels.
    Rossini A; Gazzola GB; Ravaggi A; Agostinelli E; Biasi L; Albertini A; Radaeli E; Cariani E
    Transfusion; 1995 Feb; 35(2):108-11. PubMed ID: 7529954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody to hepatitis C virus in patients with chronic schistosomiasis.
    Uemura K; Kawaguchi T; Sodeyama T; Kiyosawa K
    Ann Trop Med Parasitol; 1992 Jun; 86(3):257-62. PubMed ID: 1333179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection.
    Nelson DR; Lim HL; Marousis CG; Fang JW; Davis GL; Shen L; Urdea MS; Kolberg JA; Lau JY
    Dig Dis Sci; 1997 Dec; 42(12):2487-94. PubMed ID: 9440625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of hepatitis C virus (HCV) viraemia upon serum aminotransferase activity in chronic dialysis patients.
    Fabrizi F; Lunghi G; Andrulli S; Pagliari B; Mangano S; Faranna P; Pagano A; Locatelli F
    Nephrol Dial Transplant; 1997 Jul; 12(7):1394-8. PubMed ID: 9249775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum levels of soluble interleukin-2 receptors and effects of interferon-alpha for patients with chronic hepatitis C virus.
    Hayashi J; Kishihara Y; Yamaji K; Yoshimura E; Ohmiya M; Tani Y; Ikematsu H; Kashiwagi S
    Dig Dis Sci; 1995 Aug; 40(8):1837-41. PubMed ID: 7648988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical importance of assessment of anti-HCV IgM antibodies in chronic hepatitis C.
    Stránský J; Honzáková E; Vandasová J; Horejsová M; Kyncl J; Nĕmecek V; Horák J
    Acta Virol; 1996 Apr; 40(2):61-5. PubMed ID: 8886113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Studies on the relationship between purified alpha class glutathione S-transferase (GST-alpha) and hepatocellular damage].
    Ren H; Li C; Tan Z; Wang Y; Chen X; Zhou H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):232-6. PubMed ID: 15617336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of hepatitis C virus infection on circulating levels of sICAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC.
    Helaly GF; Abou Shamaa LA
    Egypt J Immunol; 2006; 13(1):27-38. PubMed ID: 17974148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels.
    Puoti C; Magrini A; Stati T; Rigato P; Montagnese F; Rossi P; Aldegheri L; Resta S
    Hepatology; 1997 Dec; 26(6):1393-8. PubMed ID: 9397976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities.
    Silini E; Bono F; Cividini A; Cerino A; Bruno S; Rossi S; Belloni G; Brugnetti B; Civardi E; Salvaneschi L
    Hepatology; 1995 Feb; 21(2):285-90. PubMed ID: 7843695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.